Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995202 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Letermovir prophylaxis for cytomegalovirus in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation.
Bone Marrow Transplant
January 2025
Department of Hematology and Oncology, Children's Hospital of Soochow University, Suzhou, China.
Successful Management of Refractory Cytomegalovirus Infection After Intestinal Transplantation Using Maribavir.
Transpl Infect Dis
December 2024
Department of Surgery, Far Eastern Memorial Hospital, New Taipei, Taiwan.
Congenital cytomegalovirus infection despite valaciclovir secondary prevention: should we fear antiviral resistance?
Eur J Obstet Gynecol Reprod Biol
December 2024
Department of Laboratory Medicine, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain, Brussels, Belgium.
Increased Epstein‒Barr virus reactivation following prophylaxis for cytomegalovirus infection after haploidentical haematopoietic stem cell transplantation.
J Hematol Oncol
October 2024
National Clinical Research Center for Hematologic Diseases, the First Affiliated Hospital of Soochow University, Suzhou, 215006, Jiangsu, China.
Article Synopsis
- Letermovir (LTV) prophylaxis significantly reduces the incidence of clinically significant cytomegalovirus (CMV) infection after allogeneic hematopoietic stem cell transplantation (allo-HSCT).
- A study of 230 patients показал that those receiving LTV experienced a higher rate of Epstein-Barr virus (EBV) reactivation (27%) compared to those who did not receive LTV (13%).
- Despite the increased EBV reactivation, there were no major differences in recovery metrics, overall survival, or other complications between the LTV and control groups, suggesting a possible link between LTV use and increased EBV reactivation post-transplant.
Towards improved management of pulmonary herpes simplex virus and cytomegalovirus in COVID-19 ARDS: a future perspective. Author's reply.
Intensive Care Med
December 2024
Intensive Care Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!